agilon health, inc. (NYSE:AGL) Shares Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in agilon health, inc. (NYSE:AGL) by 6.3% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 640,048 shares of the company’s stock after purchasing an additional 37,725 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in agilon health were worth $2,515,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in the stock. AQR Capital Management LLC grew its position in shares of agilon health by 3,338.5% in the 2nd quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock valued at $8,871,000 after buying an additional 1,316,990 shares during the last quarter. Susquehanna Fundamental Investments LLC boosted its stake in agilon health by 65.0% in the second quarter. Susquehanna Fundamental Investments LLC now owns 804,594 shares of the company’s stock valued at $5,262,000 after acquiring an additional 316,856 shares in the last quarter. Citigroup Inc. grew its holdings in shares of agilon health by 2,251.5% during the third quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock worth $7,971,000 after purchasing an additional 1,941,993 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund acquired a new stake in shares of agilon health during the second quarter worth about $1,849,000. Finally, Neo Ivy Capital Management purchased a new stake in shares of agilon health in the 2nd quarter valued at about $1,006,000.

agilon health Stock Performance

NYSE AGL opened at $2.24 on Friday. The stock has a market capitalization of $922.92 million, a price-to-earnings ratio of -2.38 and a beta of 0.51. The business’s 50 day moving average is $2.44 and its two-hundred day moving average is $4.38. agilon health, inc. has a 12-month low of $1.50 and a 12-month high of $13.76. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06.

agilon health (NYSE:AGL) last announced its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The business had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.47 billion. During the same period in the prior year, the company earned ($0.06) EPS. Research analysts expect that agilon health, inc. will post -0.52 EPS for the current year.

Insider Activity

In other news, Director Diana Mckenzie acquired 12,500 shares of agilon health stock in a transaction that occurred on Monday, November 25th. The stock was purchased at an average cost of $2.28 per share, with a total value of $28,500.00. Following the completion of the acquisition, the director now owns 51,319 shares in the company, valued at $117,007.32. This trade represents a 32.20 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Karen Mcloughlin bought 25,000 shares of the firm’s stock in a transaction on Friday, December 13th. The shares were purchased at an average price of $2.20 per share, for a total transaction of $55,000.00. Following the completion of the transaction, the director now owns 73,166 shares of the company’s stock, valued at $160,965.20. This represents a 51.90 % increase in their position. The disclosure for this purchase can be found here. Insiders purchased 90,000 shares of company stock worth $198,100 in the last 90 days. 3.20% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the company. JMP Securities downgraded agilon health from an “outperform” rating to a “market perform” rating in a research note on Monday, November 11th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $3.00 target price on shares of agilon health in a report on Tuesday, November 19th. Barclays decreased their price target on shares of agilon health from $5.00 to $2.00 and set an “underweight” rating for the company in a research note on Monday, November 11th. Citigroup dropped their price objective on shares of agilon health from $2.50 to $1.75 and set a “sell” rating on the stock in a research note on Wednesday, November 13th. Finally, TD Cowen decreased their target price on shares of agilon health from $6.00 to $2.00 and set a “hold” rating for the company in a research note on Monday, November 11th. Three analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $4.38.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.